Mayer Labs to relaunch the Today Sponge
BERKELEY, Calif. Mayer Labs on Tuesday announced that it will relaunch the Today Sponge, possibly marking the fourth time the over-the-counter birth control product has been introduced to the U.S. market.
According to Mayer, the product already has distribution through CVS, Walgreens and Duane Reade, three retailers who had carried the product before.
Today Sponge was originally introduced in 1983 and removed from the market due to manufacturing problems in 1994, according to published reports. The product was reintroduced into U.S. stores in 2005 by Allendale Pharmaceuticals, which was acquired by Synova Healthcare Group in 2007. Synova “re-launched” the Today Sponge soon after it acquired Allendale, but filed for bankruptcy protection later that year. Now Mayer has acquired the manufacturing and distribution rights to the birth control product.
“We are very pleased to add the Today Sponge to our portfolio of high quality reproductive products,” stated David Mayer, CEO of Mayer Labs. “The recent interruption of distribution was not the result of product quality or consumer demand, but was due to the previous owner, Synova Healthcare Group, filing bankruptcy.”
The Today Sponge is being relaunched with new packaging and Web site. Suggested retail price for a 3-pack is $14.99.
New warnings added to prescribing information for cancer drug
ROCKVILLE, Md. The Food and Drug Administration last week posted a notification to healthcare professionals around the safety profile of the cancer drug Tarceva to its MedWatch Web site.
Adverse events associated with the drug include gastrointestinal perforation (including fatalities), bullous, blistering and exfoliative skin conditions including cases suggestive of Stevens-Johnson syndrome/toxic epidermal necrolysis, in some cases fatal, and ocular disorders, including corneal perforation or ulceration have been reported during use of Tarceva.
The new safety information comes from routine pharmacovigilance activities of clinical study and postmarketing reports, the FDA stated.
New Elations formula delivers improved joint comfort
CINCINNATI According to a recent clinical study, newly-formulated Elations drink supplement with increased boron delivers improved joint comfort in as little as six days, the Elations Company stated Monday.
“By increasing the level of boron, which studies have shown helps to address some of the causes of joint discomfort, we are providing consumers a fast, safe, effective way to obtain improved comfort for their joints,” stated Robert Sarama, Elations Chief Scientist. “These benefits coupled with the benefits of glucosamine and chondroitin and an easily-absorbed, refreshing, convenient drinkable form, osteoarthritis sufferers are addressing the source of discomfort and creating building blocks for healthier, more flexible joints.”
The new Elations formula will replace the current Elations product on store shelves beginning in May 2009. The addition of boron will not affect the price of the product, the company stated.